1. Home
  2. DFDV vs SEER Comparison

DFDV vs SEER Comparison

Compare DFDV & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DFDV

DeFi Development Corp.

N/A

Current Price

$3.09

Market Cap

93.4M

Sector

Finance

ML Signal

N/A

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$2.09

Market Cap

97.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFDV
SEER
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.4M
97.3M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
DFDV
SEER
Price
$3.09
$2.09
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$45.00
N/A
AVG Volume (30 Days)
539.9K
924.2K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.40
EPS
N/A
N/A
Revenue
$2,099,660.00
$16,578,000.00
Revenue This Year
$32.58
$2.14
Revenue Next Year
$23.65
$25.90
P/E Ratio
N/A
N/A
Revenue Growth
4.82
16.99
52 Week Low
$2.44
$1.55
52 Week High
$20.30
$2.41

Technical Indicators

Market Signals
Indicator
DFDV
SEER
Relative Strength Index (RSI) 57.82 46.48
Support Level $3.04 $1.85
Resistance Level $3.35 $2.09
Average True Range (ATR) 0.19 0.07
MACD 0.06 -0.02
Stochastic Oscillator 71.74 27.78

Price Performance

Historical Comparison
DFDV
SEER

About DFDV DeFi Development Corp.

DeFi Development Corp is a U.S. company committed to building its treasury around Solana (SOL), a fast-growing blockchain infrastructure platform. This equity delivers shareholders tangible exposure to SOL price movement and staking rewards, making the firm a proxy for the Solana ecosystem. The treasury extends to running its own validator infrastructure, allowing DFDV to actively participate in and benefit from the Solana network expansion. The firm has two segments: Digital Asset Treasury ("Treasury") and Real Estate Platform ("Real Estate"). The company generates the majority of its revenue from the Treasury segment.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: